Description
Laboratory Control has been the largest identifiable area of
cGMP observations of non-compliance during FDA
inspections for the past decade. Recently the FDA changed
its inspectional technique to focus on systems. The emphasis
of this seminar will be the Laboratory Control System
identified in the FDA Systems Inspection Program and the
relationship of the Laboratory Control System components to
the cGMPs (21CFR210 and 211) and FDA and ICH guidance
documents. Discussions include examples of investigational
observations. Discussions, workshops and course notes
include assessment checklists.
01/01/0001
To
01/01/0001
Training Company
The Center for Professional Advancement (CfPA)
Industry
Clinical Research Organization
Course Category
Address
New Brunswick, NJ
New Brunswick,